000 | 00973 a2200325 4500 | ||
---|---|---|---|
005 | 20250512075345.0 | ||
264 | 0 | _c19850419 | |
008 | 198504s 0 0 eng d | ||
022 | _a0004-1556 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNehls, D G | |
245 | 0 | 0 |
_aRecent experience with chemonucleolysis: community standards and factors affecting outcome. _h[electronic resource] |
260 |
_bArizona medicine _cFeb 1985 |
||
300 |
_a74-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aChymopapain _xtherapeutic use |
650 | 0 | 4 |
_aEndopeptidases _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntervertebral Disc Displacement _xsurgery |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
700 | 1 | _aHarrington, T R | |
700 | 1 | _aGreen, J R | |
773 | 0 |
_tArizona medicine _gvol. 42 _gno. 2 _gp. 74-9 |
|
999 |
_c3889647 _d3889647 |